NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Astea

(ATEA)

upgraded to buy at TheStreet Ratings.

Berkshire Hathaway

(BRK.B) - Get Report

upgraded to buy at TheStreet Ratings.

BB&T

(BBT) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 32% year-to-date.

Ball

(BLL) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $44 price target.

Berry Petroleum

(BRY) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $38 price target. Core California project has a muted growth outlook.

Citigroup

(C) - Get Report

upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $44 price target. Fundamentals should improve and the company trades at two-thirds of its tangible book value.

CBOE

(CBOE) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $27 price target. Company is facing higher costs and delaying its buyback.

Consolidated Edison

(ED) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $60 price target. Company trades at a premium valuation and there are risks surrounding the company's upcoming rate case.

Fidelity National

(FIS) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $35 price target. Industry faces long-term growth headwinds.

Fifth Third

(FITB) - Get Report

downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.

Healthcare Services

(HCSG) - Get Report

downgraded at Benchmark from Buy to Hold, Benchmark said. Valuation call, based on a $23.50 price target.

Hess

(HES) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Company faces capital efficiency concerns. $60 price target.

IDEX Corporation

(IEX) - Get Report

downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Lower organic growth prospects.

Informatica

(INFA)

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $31 price target. Company will struggle to achieve 2013 earnings expectations.

Jack in the Box

(JACK) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Stock has made a big run versus its peers. $26 price target.

KB Home

(KBH) - Get Report

downgraded at Citigroup to Sell from Neutral, Citigroup said. $12 price target. Agressive valuation considering leverage.

Knight Transportation

(KNX) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Stock will likely lag its peers in the coming quarters.

Lennar

(LEN) - Get Report

upgraded at Citigroup to Neutral from Sell, Citigroup said. $35 price target. Underperformed peers despite above average growth.

Liberty Media

(LMCA)

upgraded at Citigroup to Buy from Neutral, Citigroup said. $121 price target. Moving toward hard control of Sirius.

Microchip

(MCHP) - Get Report

upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $38 price target. Recent acquisitions should add to earnings.

ON Semiconductor

(ONNN)

upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. New CFO will drive to improve profitability. $8 price target.

Palo Alto

(PANW) - Get Report

rated new Outperform at JMP. $77 price target. Company can capitalize on explosive demand for next-generation security.

PNC Financial

(PNC) - Get Report

upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $71 price target. Stock has lagged its peers for too long. $71 price target.

SAIC

(SAI)

downgraded at JP Morgan from Neutral to Underperform, JP Morgan said. $11 price target. Stock trades at a premium to its peers, even though the company still has to restructure.

Sirius XM

(SIRI) - Get Report

rated new Buy at BofA/Merrill. $3.75 price target. Company can leverage its premier content and growing subscriber base.

Silgan

(SLGN) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $44 price target. Stock should lag its peers in the coming quarters.

Safeway

(SWY)

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Expect the company to lag its peers in the coming quarters.

Integrys Energy

(TEG)

upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $59 price target. Asset purchase should boost the rate base.

Tyler Technologies

(TYL) - Get Report

rated new Buy at ThinkEquity. $50 price target. Company is a market leader and can continue to gain market share.

Valmont

(VMI) - Get Report

downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $123 price target.

Wells Fargo

(WFC) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $36 price target. Valuation call, as the stock is up 25% year-to-date.

WR Berkley

(WRB) - Get Report

downgraded at Goldman to Sell, Goldman Sachs said. Valuation call, based on a $35 price target.

STOCK COMMENTS / EPS CHANGES

ARIAD Pharma

(ARIA)

target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating.

Anheuser-Busch InBev

(BUD) - Get Report

added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target.

Celanese

(CE) - Get Report

numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance.

Generac

(GNRC) - Get Report

estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating.

International Paper

(IP) - Get Report

numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp.

Kronos Worldwide

(KRO) - Get Report

numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating.

Pentair

(PNR) - Get Report

numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating.

Travelers

(TRV) - Get Report

cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.

STRATEGY CALLS / MARKET CALLS

MedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Electric Cars -- the Math Simply Doesn't Add Up

>>Lessons From Biotech's Best Third Quarter Stocks

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.